Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy

Show full item record



Akinrinade , O , Ollila , L , Vattulainen , S , Tallila , J , Gentile , M , Salmenpera , P , Koillinen , H , Kaartinen , M , Nieminen , M S , Myllykangas , S , Alastalo , T-P , Koskenvuo , J W & Helio , T 2015 , ' Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy ' , European Heart Journal , vol. 36 , no. 34 , pp. 2327-2337 .

Title: Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy
Author: Akinrinade, Oyediran; Ollila, Laura; Vattulainen, Sanna; Tallila, Jonna; Gentile, Massimiliano; Salmenpera, Pertteli; Koillinen, Hannele; Kaartinen, Maija; Nieminen, Markku S.; Myllykangas, Samuel; Alastalo, Tero-Pekka; Koskenvuo, Juha W.; Helio, Tiina
Contributor organization: Children's Hospital
Department of Medical and Clinical Genetics
Department of Medicine
Kardiologian yksikkö
Lastentautien yksikkö
University of Helsinki
Department of Diagnostics and Therapeutics
HUS Children and Adolescents
Date: 2015-09-07
Language: eng
Number of pages: 11
Belongs to series: European Heart Journal
ISSN: 0195-668X
Abstract: Aims Genetic analysis among patients with dilated cardiomyopathy (DCM) is becoming an important part of clinical assessment, as it is in hypertrophic cardiomyopathy (HCM). The genetics of DCM is complex and therefore next-generation sequencing strategies are essential when providing genetic diagnostics. To achieve maximum yield, the diagnostic approach should include comprehensive clinical phenotyping combined with high-quality, high-coverage deep sequencing of DCM-associated genes and clinical variant classification as a basis for defining true yield in genetic testing. Our study has combined a novel sequencing strategy and clinical interpretation to analyse the yield and genotype-phenotype correlations among well-phenotyped Finnish DCM patients.Despite our increased understanding of the genetic basis of dilated cardiomyopathy (DCM), the clinical utility and yield of clinically meaningful findings of comprehensive next-generation sequencing (NGS)-based genetic diagnostics in DCM has been poorly described. We utilized a high-quality oligonucleotide-selective sequencing (OS-Seq)-based targeted sequencing panel to investigate the genetic landscape of DCM in Finnish population and to evaluate the utility of OS-Seq technology as a novel comprehensive diagnostic tool. Methods and results Using OS-Seq, we targeted and sequenced the coding regions and splice junctions of 101 genes associated with cardiomyopathies in 145 unrelated Finnish patients with DCM. We developed effective bioinformatic variant filtering strategy and implemented strict variant classification scheme to reveal diagnostic yield and genotype-phenotype correlations. Implemented OS-Seq technology provided high coverage of the target region (median coverage 410x and 99.42% of the nucleotides were sequenced at least 15x read depth). Diagnostic yield was 35.2% (familial 47.6% and sporadic 25.6%, P = 0.004) when both pathogenic and likely pathogenic variants are considered as disease causing. Of these, 20 (53%) were titin (TTN) truncations (non-sense and frameshift) affecting all TTN transcripts. TTN truncations accounted for 20.6% and 14.6% of the familial and sporadic DCM cases, respectively. Conclusion Panel-based, high-quality NGS enables high diagnostic yield especially in the familial form of DCM, and bioinformatic variant filtering is a reliable step in the process of interpretation of genomic data in a clinical setting.
Subject: Dilated cardiomyopathy
3121 General medicine, internal medicine and other clinical medicine
3111 Biomedicine
Peer reviewed: Yes
Rights: cc_by_nc
Usage restriction: openAccess
Self-archived version: publishedVersion

Files in this item

Total number of downloads: Loading...

Files Size Format View
326344af_abc5_4179_b53b_29b7150bb16b.pdf 697.1Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record